Higgins R M, Goldsmith D J, Connolly J, Scoble J E, Hendry B M, Ackrill P, Venning M C
Department of Renal Medicine, King's College Hospital, London, UK.
Postgrad Med J. 1996 Jan;72(843):41-4. doi: 10.1136/pgmj.72.843.41.
The proportion of patients with vasculitis and rapidly progressive nephritis aged 70 years or over has risen from about 10% in the 1980s to over 30% in series reported in the 1990s. This study was undertaken to examine the presentation and outcome of such older patients. Seventeen of 56 patients (30%) who presented at two renal units were aged 70 years or over. Mean creatinine level at presentation was 530 mumol/l, and five patients received dialysis at presentation. Outcome was dependent on three factors, namely comorbid pathology, response to immunosuppressive therapy, and the occurrence in three cases of temporary spontaneous partial remission. Overall patient survival at one and two years was 62.5% and 50%, respectively, and 90% and 100% of surviving patients were independent of dialysis at one and two years, respectively. Response to chemotherapy was excellent, with full rehabilitation in many cases and no deaths directly attributable to adverse effects of immunosuppressive therapy. We conclude that diagnosis of vasculitis and rapidly progressive glomerulonephritis by renal biopsy and the subsequent administration of chemotherapy (including cyclophosphamide in many cases) resulted in a worthwhile benefit in these elderly patients.
血管炎合并快速进展性肾炎患者中,70岁及以上患者的比例已从20世纪80年代的约10%升至20世纪90年代系列报道中的30%以上。本研究旨在调查这类老年患者的临床表现及预后。在两个肾脏科就诊的56例患者中有17例(30%)年龄在70岁及以上。就诊时平均肌酐水平为530μmol/L,5例患者就诊时即接受透析治疗。预后取决于三个因素,即合并病变、对免疫抑制治疗的反应以及3例出现的暂时性自发部分缓解。患者1年和2年的总体生存率分别为62.5%和50%,存活患者中1年和2年时分别有90%和100%无需透析。化疗反应良好,许多病例实现了完全康复,且无直接归因于免疫抑制治疗不良反应的死亡病例。我们得出结论,通过肾活检诊断血管炎和快速进展性肾小球肾炎并随后进行化疗(许多病例包括环磷酰胺),对这些老年患者产生了有益的效果。